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haptoglobin and serum amyloid A, as serum
biomarkers during active sheep scab infestation
Beth Wells1*, Giles T Innocent2, Peter D Eckersall3, Eilidh McCulloch4, Alasdair J Nisbet1 and Stewart TG Burgess1Abstract
Two ruminant acute phase proteins (APPs), haptoglobin (Hp) and serum amyloid A (SAA), were evaluated as serum
biomarkers (BMs) for sheep scab–a highly contagious ectoparasitic disease caused by the mite Psoroptes ovis, which
is a major welfare and production threat worldwide. The levels of both APPs increased in serum following
experimental infestation of sheep with P. ovis, becoming statistically significantly elevated from pre-infestation levels
at 4 weeks post-infestation. Following successful treatment of infested sheep with an endectocide, Hp and SAA
serum levels declined rapidly, with half lives of less than 3 days. In contrast, serum IgG levels which specifically
bound the P. ovis-derived diagnostic antigen Pso o 2 had a half-life of 56 days. Taking into account pre-infestation
serum levels, rapidity of response to infestation and test sensitivity at the estimated optimum cut-off values, SAA
was the more discriminatory marker. These studies illustrated the potential of SAA and Hp to indicate current sheep
scab infestation status and to augment the existing Pso o 2 serological assay to give disease-specific indications of
both infestation and successful treatment.Introduction
Sheep scab, caused by the infestation of sheep skin with
the highly contagious mite Psoroptes ovis, affects the
productivity and welfare of sheep as it produces in-
tensely pruritic lesions and wool loss. These factors,
along with the high cost of treatment, mean this disease
has significant economic implications for the sheep in-
dustries of affected countries [1]. In the UK, the inci-
dence of the disease has increased to a level that it is
now endemic [2] with the national annual prevalence es-
timated at > 7000 outbreaks [3]. This has resulted in the
disease being made notifiable in a number of countries
(e.g. in Scotland through the Sheep Scab (Scotland)
Order 2010 [4]), which has renewed the focus on accur-
ate diagnosis for effective control. Accurate diagnosis
can be challenging - clinical signs in P. ovis infested
sheep may be minimal during early infestation (up to
several months in the field) and easily missed but these
animals represent a source of infestation [5]. In such a* Correspondence: beth.wells@moredun.ac.uk
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reproduction in any medium, provided the orsituation, mites can be difficult to locate and the sensi-
tivity of the microscopic detection of mites in skin
scrapings from these animals can be as low as 18% [6].
In addition to P. ovis, other ectoparasites such as ticks
and lice can induce skin reactions which may appear
similar to those seen in early infestation with P. ovis
[7,8] and dual infestations with more than one ectopara-
site are common. The difficulties highlighted above in
the control and diagnosis of sheep scab illustrates the re-
quirement for a sensitive and specific test which would
indicate early infestation and also current disease status.
Several immunoassays have been developed to detect
serum antibodies with specific reactivity to P. ovis anti-
gens from infested sheep [9-11]. Recently we have suc-
cessfully developed a diagnostic test which detects the
host’s antibody response to the P. ovis antigen Pso o 2.
This test is highly specific and sensitive and can detect
serum antibodies to Pso o 2 as early as two weeks post-
infestation [12]. However, due to antibody persistence of
several months in the serum, the test cannot distinguish
between currently-infested and recently-(successfully)
treated sheep [13]. This is an important factor in any
control or eradication regime where demonstration oftd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Sera samples used to test APP responses during
common infections and conditions of sheep
Infection / condition Number of samples
Early gestationa 10
Late gestationb 10
Gastro-intestinal nematodesc 6
Liver Fluke (Fasciola hepatica)d 6
Sucking lice (Linognathus spp.)e 4
Chewing lice (Bovicola ovis)e 4
Orff 6
Johnes diseaseg 6
aEarly gestation was within 1 week of conception and blate gestation was
1 week prior to expected lambing date (samples from Moredun Research
Institute (MRI)). cSamples from sheep with field-acquired gastro-intestinal
nematode (GIN) infections were from Firth Mains Farm, UK (MRI); species in-
cluded Teladorsagia circumcincta and Nematodirus battus. dSamples were taken
from UK sheep with field-acquired infections of liver fluke (samples provide by
Dr H McDougall, MRI); esamples from lice infected but P. ovis-uninfested sheep
(provided by Prof. N. Sargison, R(D)SVS, UK; fsamples from sheep infected ex-
perimentally with orf virus or gMycobacterium avium subspecies
paratuberculosis (MRI).
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of legislation on movement restrictions etc. Therefore,
an improved diagnostic test for sheep scab should combine
the pathogen specificity and early indication of infestation
(as provided by the Pso o 2 ELISA [12]) with a biomarker
(BM) element to differentiate between successfully-treated
animals and those with active disease.
Ideally, BMs should circulate at low levels in the
serum of healthy individuals, increase in titre rapidly fol-
lowing the onset of disease and return to pre-infestation
levels soon after successful treatment or disease reso-
lution [14]. As this describes the behaviour of inflamma-
tory proteins and, as sheep scab produces an acute
inflammatory response within hours of infestation [15],
we investigated two ruminant acute phase proteins
(APPs)–haptoglobin (Hp) and serum amyloid A (SAA)–as
BMs for sheep scab. Ruminants are unique in that Hp is a
major APP [16] and in sheep, as for cattle, APP produc-
tion continues in chronic as well as acute infections, with
roles in tissue repair. In cattle, Hp is synthesised only in
response to inflammation [17] and Hp levels have been
used extensively to monitor inflammatory disease [18] but
to date there has been very little work on the acute phase
response in sheep [16].
This study investigates qualitative and quantitative
serum levels of Hp and SAA in sheep during experimen-
tal infestations with P. ovis and the effects of successful
treatment on these APPs; reports Hp and SAA levels
during other common conditions and diseases of sheep
and in sheep diagnosed as clinically positive during a
natural outbreak of sheep scab.
Materials and methods
Samples used in APP evaluation
Time course trial
To supply sera for initial immunoblot analyses, blood was
sampled from each of 6 Scotch Mule mixed sex 1-2 year
old sheep, by venous extraction, prior to infestation with
P. ovis. Following infestation on the withers with approxi-
mately 50 mites, blood was sampled weekly from each ani-
mal for 6 weeks and sera were prepared by centrifuging
whole blood at 900 g for 10 min. Sera were then stored
at −20 °C until use. This part of the study was termed
the “time-course trial” (TCT).
Primary infestation and treatment trial
For the quantitative analysis of Hp and SAA, sera were
obtained from 12 P. ovis-naïve, Scotch Mule, mixed sex,
1-2 year old sheep infested with P. ovis mites as de-
scribed above. Blood samples were acquired before
exposure and then weekly over a 6 week period post-
infestation. At 6 weeks post-infestation, all twelve
sheep were treated with an injectable endectocide
(Dectomax, Pfizer Animal Health) by intramuscularinjection at a dose of 1 mL per 33 kg bodyweight and
blood was then sampled twice weekly for 2.5 weeks;
then at 4, 9 and 14 weeks post-treatment. This part
of the study was termed the “primary infestation and
treatment” (PIT) trial.
Secondary infestation and treatment trial
Fourteen weeks post-treatment the sheep were re-infested
with P. ovis and blood samples were taken at 24 hours
post-infestation then weekly for a further 6 weeks. On
week 6, sheep were treated with endectocide again, as de-
scribed above, and blood was then sampled twice weekly
for a further 2.5 weeks. This part of the study was termed
the “secondary infestation and treatment” (SIT) trial. Sera
were prepared from each of the blood samples by centrifu-
ging whole blood at 900 g then sera were stored at −20 °C
until use. Lesion areas were measured at the time of
each blood sampling post-infestation until 2 weeks
post-treatment by measuring the length and width of
the main lesion on each sheep and recording the result
as an average mean lesion area (cm2) ± SEM.
Field acquired infestations
In addition to these sera from experimental infestations,
sera were also acquired from sheep with field-acquired
sheep scab infestations (n = 12). Sera were available for
these animals pre-infestation, at point of clinical diagno-
sis and two months post-treatment [13].
Other common infections
To test the specificity of the Hp and SAA response, the
samples listed in Table 1 were used to analyse Hp and
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tions of sheep.
Qualitative analyses of the APPs: Haptoglobin (Hp) and
Serum Amyloid A (SAA)
Sera from each of 6 sheep in the TCT study were pooled
according to time point post-infestation and were then
diluted 1:10 with dH₂O. Polyacrylamide gel electrophor-
esis (SDS-PAGE), under denaturing conditions, was per-
formed using NuPage BisTris 4-12% polyacrylamide gels
(Invitrogen) with MES buffer (Invitrogen) according to
the manufacturer’s instructions.
Gels were stained in SimplyBlue Safestain (Invitrogen)
following the manufacturer’s protocol. Bands which in-
creased in intensity through the time course of infest-
ation were excised from the gel and identified using
matrix assisted laser desorption ionization (MALDI) at
the Moredun Proteomics Facility: Excised bands were
destained and subjected to reductive alkylation using
DTT and iodoacetamide. Gel pieces were digested over-
night at 37 °C in trypsin and digests analysed on an
Ultraflex II MALDI-ToF-ToF mass spectrometer (Bruker
Daltonics). The masses obtained were used for database
searching with the MASCOT search engine using Swiss-
Prot and local databases with a 50 ppm mass tolerance
window. Significant matches from the Peptide Mass Fin-
gerprint data were confirmed by MS/MS analysis using
the search criteria above and an MS/MS tolerance win-
dow of 0.5 Da.
Immunoblotting was performed using sera from indi-
vidual sheep with different disease progression profiles
in the TCT trial. Sheep 1 had a naturally-resolving le-
sion, which was at maximum size at week 4 post-
infestation, whilst the lesion from Sheep 5 and 6 showed
a gradual expansion over the time course of infestation.
Sera from these sheep from each time point in the TCT
trial were separated by SDS-PAGE as described above
and then transferred to a nitrocellulose membrane by
electroblotting using the iBlot Western Blotting system
(Invitrogen), following manufacturer’s instructions. The
blot was blocked using 3% gelatin from cold water fish
skin (Aldrich) for 30 min prior to washing with washing
buffer/antibody diluent (10% PBS; 90% dH₂O, 29.22 g
NaCl and 5 mL Tween 80 (Sigma-Aldrich). The blot was
incubated with the following antibodies for 1 h with wash-
ing in between incubations: The primary antibody used
for detecting Hp in the electrophoresed serum samples
was a rabbit polyclonal anti-human Hp (Abcam, ab85846)
used at a concentration of 1 μg/mL. The secondary anti-
body conjugate used was a swine anti-rabbit IgG HRP
conjugate (Dako, P0399) used at a concentration of
0.5 μg/mL. Visualisation was by ECL Plus (GE Health-
care) using the ImageQuant system (GE Healthcare).
The primary antibody for the detection of SAA was arabbit polyclonal anti-human recombinant SAA (Abcam,
ab59736) used at a concentration of 2 μg/mL. The conju-
gate was a swine anti-rabbit HRP IgG (Dako P0399) used
at a concentration of 0.5 μg/mL. Band densities were esti-
mated using the Quantity One software 4.6.2 (Bio-Rad).
Quantitative analyses of the AAPs
Hp concentrations were determined by ReactivLab and
Glasgow University using a colorimetric assay (Reactiv-
Lab Ltd, Wetherby, UK) based on the method described
by Eckersall et al. [19] and modified as described in
International Patent Application WO 2012/085497 A1.
Validation of this cross species assay for Hp was de-
scribed in Crawford et al. [20]. For determination of the
concentration of Hp in ovine serum the assay was fur-
ther validated. The intra-assay coefficient of variance
(CV) was 5.5% calculated as the mean of CVs of samples
(n = 47) run in duplicate in one assay, the inter-assay
CVs using quality control samples of ovine serum were
6.5% at a mean Hp of 0.34 g/L (n = 7), 5% at a mean Hp
of 0.71 g/L (n = 7) and 11.5% at a mean Hp of 1.01 g/L
(n = 5). The limit of detection was 0.02 g/L determined
as the concentration of Hp at 3 standard deviations from
the mean of a blank sample. Hp concentrations were
quantified in sheep sera from the PIT and SIT trials;
from the field-acquired P. ovis infestations and from
sheep with other common conditions (Table 1). The Hp
assay was performed on an ABX Pentra 400 analyser
(Horiba Medical) using a calibration curve with a top
Hp standard of 1.48 mg/mL such that samples with Hp
values greater than this were automatically diluted. All
samples were tested in duplicate.
For SAA, a commercially-available ELISA kit (TP-802,
Tridelta Development Ltd) was used to quantify levels of
this APP in sheep sera. The manufacturer’s protocol was
followed using the same sera samples as described above
for Hp. Samples were tested from individuals in dupli-
cate alongside a SAA standard curve and all serum was
diluted 1:500 in sample diluent buffer (Tridelta Develop-
ment Ltd). The upper level of the range of the bovine
standards used was 300 ng/mL therefore all sera samples
showing SAA values greater than this were further di-
luted as required and re-analysed.
Analysis of serum IgG levels to the mite antigen Pso o 2
An ELISA which measures the levels of Pso o 2-specific
IgG in sheep serum [12] was used to allow post-infestation
comparisons of Pso o 2-specific IgG synthetic and decay
profiles (post-treatment) with those of Hp and SAA. Serum
samples from the PIT and SIT experimental trials were
used to assess persistence in antigen-specific IgG levels
after treatment [11,13]. Serum samples were analysed up
to, and including, 14 weeks post-treatment. The ELISA
was performed as previously described [12] with the
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Figure 1 Skin lesion areas for sheep over a 6 week time course
of infestation with Psoroptes ovis and 2 weeks post-treatment
(PIT trial data). *Values shown are means (± SEM, n = 12). All
animals treated with Dectomax (Pfizer Animal Health) at
6 weeks post-infestation.
Figure 2 Profile of serum proteins from sheep infested with P.
ovis over a 6 week time course (TCT trial). Lane 1 = SeeBlue
Marker (Invitrogen); Lane 2 = pre-infestation sera; Lane 3 = week 1
post-infestation sera; Lane 4 = week 2 post-infestation sera; Lane 5 =
week 3 post-infestation sera; Lane 6 = week 4 post-infestation sera;
Lane 7 = week 5 post-infestation sera; Lane 8 = week 6 post-
infestation sera; Lane 9 = hyper immune sera. Gel stained with Sim-
plyBlue Safestain (Invitrogen). Bands excised for MALDI analysis at 17
and 38 kDa are circled in red.
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for individual sheep in duplicate. Positive, inter-plate
controls were used from sheep (n = 2) which had been
re-infested with P. ovis for 6 weeks following a primary
infestation (6 weeks) and effective treatment. Negative
controls consisted of the pre-infestation sera from the
PIT trial sheep.
Statistical analysis
Initial statistical analyses of Hp and SAA levels in the
PIT and SIT trials were performed using repeated mea-
sures one-way analysis of variance (ANOVA) with a
Tukey’s post-hoc test and performed in Graph Pad
Prism (Version 5.05, GraphPad Software Inc). Further
statistical analyses were performed by Biomathematics
and Statistics Scotland (BioSS) using the R Statistical
Package [21]: Best fit models were identified to describe
Hp, SAA and Pso o 2-specific IgG trends (as “normal”
or “elevated” compared to pre-infestation levels) over
the time course of infestation and post-treatment; half
life values were calculated using a generalised linear
mixed model to describe the exponential decay of the
BMs and Pso o 2-specific IgG and incorporated a ran-
dom effect of animal on the decay constant, and the ini-
tial value. In addition, optimised cut-off values were
calculated, where the objective was to obtain as high
sensitivity and specificity as possible to keep false results
to a minimum. This was achieved using a generalised
linear mixed model for binomial data, with a logit link
which required the use of the library “lme4” [22].
Results
Qualitative analyses of the APPs: Hp and SAA from the
TCT trial
Mean lesional areas are shown in Figure 1 and illustrate
gradual lesion growth until week 4 post-infestation, followed
by rapid expansion between week 4 to week 6 post-
infestation. Post-treatment, the lesions resolved slowly and
measurement was stopped 2 weeks after treatment due to
the nature of lesion healing as they healed and lifted off ra-
ther than decreased in size.
The densities of two bands, with approximate molecu-
lar masses of 17 and 38 kDa, increased through the time
course of infestation with P. ovis, with maximum abun-
dance at weeks 5 and 6 post-infestation (Figure 2).
MALDI analysis identified both bands as fragments of
Hp. As the ovine Hp sequence has not yet been depos-
ited in public databases, the polypeptide with highest
homology to the 17 kDa band was Capra ibex Hp with
sequence coverage of 35.7% and intensity coverage of
79.7% (mascot score 127). For the 38 kDa sample, the
polypeptide with highest homology was Cervus elaphus
Hp with an intensity coverage of 11.3% and sequence
coverage of 14.5% (mascot score 202).Using immunoblot and densitometry analysis, along with
lesion area data from trial TCT, it was demonstrated that,
as the lesion size increased, the band density of Hp (at
45 kDa) also increased and as the lesion resolved the inten-
sity of the bands decreased (Figure 3). For SAA, the dens-
ities of bands obtained in immunoblots, at the estimated
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Figure 3 Relationship between lesion area and serum Hp during a 6 week infestation of sheep with Psoroptes ovis. Panel a: Serum from
a sheep infested with P. ovis in trial TCT where the lesion resolved naturally after 4 weeks (Sheep 1); Panel b: Serum from an infested sheep in the
same trial where the lesion had continued to expand during the 6 week time course (Sheep 5). Immunoblots were probed with a rabbit
polyclonal anti-human Hp antibody (Abcam) and the secondary antibody conjugate used was a swine anti-rabbit IgG HRP (Dako). The image was
visualised by ECL Plus and ImageQuant. Band volumes (at 45 kDa) were quantified by ImageQuant TL software.
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a clear relationship between SAA band density and lesion
size was identified, with SAA band density peaking 2 weeks
before the lesion size peak in the lesion resolving sheep
(Figure 4a).
Quantitative analyses of the APPs
The mean Hp concentration in sheep serum pre-infestation
with P. ovis was 0.30 ± 0.06 mg/mL. There was no statisti-
cally significant increase in Hp levels at the 5% level during
the primary infestation until after 4 weeks post-infestation
(Figure 5a). Between weeks 4 and 5 post-infestation, mean
Hp levels increased from 0.83 ± 0.41 mg/mL to 3.33 ±
0.89 mg/mL (p ≤ 0.001). Following termination of the pri-
mary infestation with endectocide, mean Hp levels fell sig-
nificantly (p ≤ 0.001) from 3.53 ± 0.64 mg/mL at the point of
treatment to 1.57 ± 0.35 mg/mL one week post-treatment0
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Figure 4 Relationship between lesion area and serum SAA during a 6
from a sheep infested with P. ovis in trial TCT where the lesion resolved na
in the same trial where the lesion had continued to expand during the 6 w
antibody raised in rabbits against human rSAA (Abcam) and the secondary
was visualised using ECL Plus (GE Healthcare) and ImageQuant. Band volumand had returned to pre-infestation levels between 10 and
14 days after treatment. During this PIT phase of the trial,
the proportion of animals with “elevated” Hp increased be-
tween weeks 4 and 5 post-infestation and all, except one,
animal had returned to “normal” by 10 days post-treatment
(Table 2). The half life of Hp levels in the serum post-
treatment was calculated as 2.3 days [95% confidence inter-
val (CI) = 1.9-2.9] and a cut-off of 1.26 mg/mL was selected,
giving an estimated sensitivity of 0.83 and a specificity of 1.0.
The Hp profile during the secondary infestation
(Figure 5a) showed that serum Hp levels increased
more rapidly following this secondary challenge than
during the primary infestation with P. ovis. Hp levels
had doubled by 24 hours post-infestation in the sec-
ondary infestation compared with the much slower increase
in levels during the primary infestation. The maximum Hp
concentration measured during the secondary infestationy
(cm²)
0
500
1000
1500
2000
2500
3000
0
100
200
300
400
500
600
700
800
900
0 1 2 3 4 5 6
Band density Lesion size
Week post infestation
b
week infestation of sheep with Psoroptes ovis. Panel a: Serum
turally after 4 weeks (Sheep 1); Panel b: Serum from an infested sheep
eek time course (Sheep 6). The blots were probed with an anti-SAA
antibody conjugate was swine anti-rabbit HRP IgG (Dako). The blot
es (at 14 kDa) were quantified by ImageQuant TL software.
0 5 10 15 20 25 30
0
1
2
3
4
5
***   ***
Treatment
Treatment
Secondary infestation
0 5 10 15 20 25 30
0
100
200
300
400
***
**
*** ***
Treatment
Treatment
Secondary infestation
0 5 10 15 20 25 30
0
1
2
3
Treatment
*
***
Re-infested
***
Treatment
a
b
c
M
ea
n 
H
p 
(m
g/m
L)
M
ea
n 
SA
A 
(µg
/m
L)
M
ea
n 
no
rm
al
is
ed
 
O
D
Week post-infestation/treatment
Week post-infestation/treatment
Week post-infestation/treatment
Figure 5 Quantitative analyses of serum acute phase protein and Pso o 2-specific IgG levels during an infestation/treatment/re-infestation model
of Psoroptes ovis in sheep. Panel a: Haptoglobin: Sera samples from individual sheep (n= 12) in the PIT and SIT trial were analysed in duplicate using a
colorimetric assay (ReactivLab). Hp concentrations are shown as mean (±SEM) through the time course of primary infestation (PIT) with P. ovis for 6 weeks,
and post-treatment over 14 weeks, followed by secondary infestation (SIT) for a further 6 weeks and post-treatment for 2.5 weeks. Panel b: SAA: Sera samples
from individual sheep (n= 12) in the PIT and SIT trial were analysed in duplicate using SAA ELISA (Tridelta Development Ltd). SAA concentrations are shown
as mean (± SEM) through the time course of primary infestation (PIT) with P. ovis for 6 weeks, and post-treatment over 14 weeks, followed by secondary
infestation (SIT) for a further 6 weeks and post-treatment for 2.5 weeks. Panel c: Pso o 2-specific IgG: Sera samples from individual sheep (n= 12) in the PIT
and SIT trial were analysed in duplicate using an ELISA in which the coating antigen was a recombinant Pso o 2 (rPso o 2) at 75 μg/mL; primary antibody
was IgG in the serum samples and the conjugate was a rabbit anti-sheep IgG HRP (Dako) at a dilution of 1:2000. IgG levels are represented as mean
normalised OD₄₅₀ values (±SEM). *p≤ 0.05; ** p≤ 0.01 and ***p≤ 0.001 as determined by repeated measures one-way ANOVA (Graph Pad Prism).
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Table 2 Distribution of sheep into “normal” and
“elevated” groups for serum Hp and SAA concentration
across the time course of primary infestation with
Psoroptes ovis and treatment with an endectocide (PIT
trial)
Biomarker Week 0 1 2 3 4 5 6** 6.5 7 7.5 8
Hp Normal* 12 11 11 11 10 4 2 2 7 11 12
Elevated 0 1 1 1 2 8 10 10 5 1 0
SAA Normal 12 9 10 11 4 0 0 7 11 12 12
Elevated 0 3 2 1 8 12 12 5 1 0 0
* The status of APP levels in sheep sera (n = 12 for each time point) was
determined by comparison to pre-infestation levels using the R
Statistical Package.
** All sheep were treated with an injectable endectocide at week 6 post-
infestation. In these analyses the animals were described as being “normal” as
in day 0 (pre-infestation) or “elevated”. As the results showed a normal distri-
bution, all values above the 0.999 quantile of the distribution were considered
to be elevated, giving a 99.9% specificity and undefined sensitivity.
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1.25 ± 0.27 mg/mL. By week 3 in the secondary infestation,
Hp levels had decreased to pre-infestation levels and
remained at low levels for the remainder of the trial.
SAA levels pre-infestation were 0.82 ± 0.53 μg/mL and
remained at this level over the first 3 weeks of primary
infestation (PIT, Figure 5b). By week 4 post-infestation,
SAA levels had increased to 95.24 ± 54.4 μg/mL and there-
after peaked at week 5 (284.75 ± 71.144 μg/mL). The
increase in serum SAA levels between weeks 3 and 5
post-infestation was highly statistically significant (p ≤
0.001). Post-treatment, serum SAA levels fell within
3 days of treatment to 57.28 ± 34.75 μg/mL (p ≤ 0.05)
and continued to decrease reaching pre-infestation
levels within 10 days post-treatment. The proportion
of animals showing elevated serum SAA increased be-
tween weeks 4 and 5 post-infestation and all except
one animal had returned to normal by 10 days post-
treatment (Table 2). The half life of SAA in the serum
post-treatment was estimated at 0.84 days (95% CI = 0.73-
0.99) and a cut-off value of 29.5 μg/mL was selected to
identify “elevated” animals above that point or “normal”
animals below it. This cut-off value provided an estimated
assay sensitivity of 1.0 and a specificity of 1.0.
The secondary infestation was characterised by a rapid
increase in SAA concentration of the same magnitude of
the primary infestation peak, but within 24 h post-
secondary infestation. Within 2 weeks of infestation,Table 3 Distribution of sheep into “normal” and “elevated” g
course of a primary infestation with Psoroptes ovis and treatm
Week 0 1 2 3 4 5 6* 7 8 9
Normal 12 9 4 3 1 1 0 0 0 0
Elevated 0 3 8 9 11 11 12 12 12 12
* All animals were treated with injectable endectocide at week 6 post-infestation. In
festation) or “elevated”. As the results showed a normal distribution, all values abov
a 99.9% specificity and undefined sensitivity.however, SAA levels had fallen to pre-infestation levels
(2.26 ± 2.46 μg/mL) and they remained at this level
until the end of the trial.
Analysis of serum IgG levels to the mite antigen Pso o 2
By week 2 post-primary infestation (PIT trial) the mean
normalised OD₄₅₀ value measured in ELISAs to detect
Pso o 2-specific IgG in sheep serum had increased from
0.57 ± 0.02 pre-infestation to 1.197 ± 0.115 (p ≤ 0.05) and
continued to increase until week 6 post-primary infest-
ation (Figure 5c). The antigen-specific IgG levels in-
creased, exponentially, over time during the primary
infestation period up to the point of treatment by 0.034
OD450 units per day (95% CI = 0.032-0.037). By week 3
post-infestation, 9 out of 12 animals showed an “ele-
vated” Pso o 2-specific IgG level (Table 3). After termin-
ation of the primary infestation with endectocide, the
mean OD₄₅₀ decreased from a 2 weeks post-treatment
value of 2.66 ± 0.07 to 1.73 ± 0.10 by 3 weeks post-treatment
(p ≤ 0.001). After this initial decline, the OD450 values con-
tinued to decline slowly and did not return to pre-
infestation levels until the start of the secondary infestation
trial, which was 14 weeks post-treatment. The half life of the
antibody levels to Pso o 2 following endectocide treatment
was estimated as being 56 days with a decay rate of 0.012
OD450 units per day (95% CI = 0.011-0.014). More than half
of the sheep in the PIT trial continued to show elevated Pso
o 2-specific IgG levels at 14 weeks post-treatment. As the
anti-Pso o 2 antibody levels increased at approximately three
times the rate at which they decreased, it is evident that
antibody levels were not an accurate measure of current dis-
ease status post-treatment, but were effective during the
early diagnosis of sheep scab during this trial.
Assessment of APP levels in sheep during a field
outbreak of sheep scab
The pre-infestation levels of Hp (0.23 ± 0.22 mg/mL)
were comparable to those, pre-infestation, in the PIT ex-
perimental trial (0.29 ± 0.06 mg/mL) (Figure 6a). Follow-
ing a field-acquired infestation with P. ovis, serum Hp
levels were statistically significantly elevated at the point of
clinical diagnosis (p ≤ 0.01) but the decrease in Hp levels
2 months post-treatment was not statistically significant.
The pre-infestation levels of SAA (1.07 ± 0.24 μg/mL)
in these sheep (Figure 6b) were marginally higher thanroups for Pso o 2-specific serum IgG across the time
ent with an endectocide (PIT trial)
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0 0 0 1 1 1 2 4 5 5 6
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this analysis the animals were described as being “normal” as in day 0 (pre-in-
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Figure 6 Quantitative analyses of serum acute phase proteins
in sheep during a field-acquired infestation with Psoroptes ovis.
Mean serum Hp (Panel a) and SAA (Panel b) concentrations (± SE)
from sheep (n = 12) pre-infestation, at the point of clinical diagnosis
of sheep scab and 2 months post-treatment with an endectocide in
a field outbreak of sheep scab. Hp measurement by commercial
assay (ReactivLab) and SAA by commercial ELISA (Tridelta Develop-
ment Ltd); sera from individual sheep diluted 1:50 for SAA assay and
assayed in duplicate in both assays. **p≤ 0.01; *p≤ 0.05 as deter-
mined by a one-way ANOVA (Graph Pad Prism).
Table 4 Serum Hp and SAA concentrations during
common sheep diseases and conditions
Infection/Condition Mean Hp
(mg/mL)
Mean SAA
(μg/mL)
Early gestationa (n = 10) 0.33 ± 0.01 9.34 ± 2.14
Late gestationb (n = 10) 0.52 ± 0.08 17.09 ± 7.77
Gastro-intestinal
nematodesc (n = 6)
0.04 ± 0.03 0.30 ± 0.01
Liver Fluke (Fasciola
hepatica)d (n = 6)
2.85 ± 0.02 0.22 ± 0.01
Sucking lice (Linognathus spp.)e
(n = 4)
0.52 ± 0.51 68.47 ± 22.33
Chewing lice (Bovicola ovis)e
(n = 4)
0.65 ± 0.31 193.36 ± 135.81
Orf (n = 6)f 0.21 ± 0.01 0.93 ± 0.53
Johnes diseaseg (n = 6) 2.25 ± 0.34 21.43 ± 10.47
Hp (mg/mL ± SEM) measured by colorimetric assay (ReactivLab) and SAA (μg/
mL ± SEM) assessed by SAA ELISA (Tridelta Development Ltd). All samples
were assayed for individual animals in duplicate. aEarly gestation was within
1 week of conception and blate gestation was 1 week prior to expected
lambing date (samples from Moredun Research Institute (MRI)). cSamples from
sheep with field-acquired gastro-intestinal nematode (GIN) infections were
from Firth Mains Farm, UK (MRI); species included Teladorsagia circumcincta
and Nematodirus battus. dSamples were taken from UK sheep with field-
acquired infections of liver fluke (samples provide by Dr H McDougall, MRI);
esamples from lice infected but P. ovis-uninfested sheep (provided by Prof. N.
Sargison, R(D)SVS, UK; fsamples from sheep infected experimentally with orf
virus or gMycobacterium avium subspecies paratuberculosis (MRI).
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At point of clinical diagnosis the recorded mean SAA
(10.69 ± 2.66 μg/mL) was statistically significantly higher
than the pre-infestation level (p ≤ 0.01) and, unlike Hp,
the decrease in SAA post-treatment was also statistically
significant (p ≤ 0.05, Figure 6b).
Hp and SAA levels during other common sheep infections
and conditions
The serum Hp and SAA levels measured during most
other common sheep infections were similar to those mea-
sured in sheep prior to infestation with P. ovis (Table 4).For example Hp and SAA levels during experimental gastro-
intestinal nematode infections were 0.04 ± 0.03 mg/mL and
0.30 ± 0.01 μg/mL respectively. The exceptions to this were
during liver fluke infection and Johnes disease, where Hp
levels were 2.85 ± 0.02 mg/mL and 2.25 ± 0.34 mg/mL
respectively, which are of the same magnitude as those
measured 4-5 weeks post-infestation with P. ovis. SAA
levels during chewing and sucking lice infestations also
showed the same magnitudes as 4-5 weeks post-
infestation with P. ovis at 193.36 ± 135.81 μg/mL and
68.47 ± 22.33 μg/mL respectively.
Discussion
Here we identified, by proteomic and semi-quantitative
immunoproteomic techniques, serum Hp and SAA as
potential biomarkers for active sheep scab infestation.
The qualitative results for SAA in the lesion resolving
sheep (Figure 4a) where the band densities increased
then decreased around 2 weeks before the lesion size
changes, suggested that SAA levels in the serum of
infested sheep may increase before obvious clinical signs
were apparent, which would be an important factor in
the pre-clinical diagnosis of sheep scab. However, when
the levels of SAA and Hp in sera were quantified using
assays, it was demonstrated that both APPs increased in
serum concentration as P. ovis infestation progressed,
but did not show statistically significant increases (p ≤
0.001) until weeks 4–5 post-infestation. Previous studies
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during a range of inflammatory diseases in ruminants
[16,23,24], but this is the first report of their elevation
during sheep scab disease.
During a six week experimental infestation of sheep
with P. ovis, Hp levels in serum increased by more than
10-fold to 3.5 mg/mL compared with pre-infestation
levels, whereas SAA levels increased approximately 1000-
fold in the same period to 211 μg/mL. These levels were
similar to those of Hp and SAA measured in Alpine ibex
(Capra ibex) infested with clinical sarcoptic mange
(Sarcoptes scabiei infestation) where mean Hp levels
during naturally-acquired infestation increased to 3.72 ±
0.65 mg/mL compared with healthy, uninfested controls
(0.58 ± 0.09 mg/mL) and SAA levels were 130.7 ±
0.16 μg/mL and 8.7 ± 0.13 μg/mL in infested and
uninfested animals respectively [25]. Generally, major
APPs are present at undetectable or very low levels in
the serum of healthy animals [26] but, recently, a
study investigating the APP response to scrapie in
sheep found large individual animal variation in Hp
and SAA prior to clinical disease onset and it was
suggested that this may be due to underlying subclin-
ical conditions [27]. Previous work has indicated that
Hp and SAA are non-specific in terms of inflamma-
tory disease, injury or infection, but highly sensitive,
effective markers of inflammation in ruminants [16,24]
suggesting that any inflammatory event in the animal may
cause a temporary rise in Hp or SAA. In contrast to Hp,
serum SAA was measured at lower levels in sheep serum
prior to P. ovis infestation; mean SAA concentration pre-
infestation during the PIT trial was 0.82 ± 0.53 μg/mL,
representing only 0.29% of the peak SAA levels measured
at week 5 post-infestation. This suggests that SAA may
potentially be a more suitable BM than Hp to indicate
current disease status during P. ovis infestation in sheep
although the biochemical assay for Hp has practical ad-
vantages being an automated rapid assay which could be
incorporated into routine biochemistry profile analysis in
contrast to the ELISA system used for quantification of
SAA.
In sheep infected with bacteria causing caseous lymph-
adenitis (CLA), serum Hp and SAA levels peaked by day
7 post-infection, which is considered to be the point at
which the acute disease becomes a chronic infection
[28]. Hp and SAA have also been previously reported to
be measurable by day two post-infection in acute inflam-
matory diseases such as mastitis and metritis [16]. In
contrast, the proportion of animals with a P. ovis-in-
duced elevation in APPs did not occur until weeks 4-5
post-infestation in the case of Hp (Table 2), or margin-
ally earlier at week 4 for SAA (Table 2). A possible ex-
planation for this is that disease initiation in sheep scab
has a “lag phase” at the start of infestation lasting forseveral weeks as the mites become established, after
which the mite numbers increase exponentially [7]. Le-
sion size development follows this pattern in mite num-
bers, as the increasing numbers of mites move out from
the margins of the lesion onto healthy skin, as shown by
the lesion size data recorded in the TCT trial (Figure 1).
In order for a biomarker to be useful in the diagnosis
of current disease status in sheep exposed to P. ovis, it is
crucial that its levels in the serum decline rapidly after
treatment or disease resolution. This study has demon-
strated that Hp and SAA return to pre-infestation levels
rapidly following termination of P. ovis infestation, with
half-lives of 2.3 days for Hp and 0.84 days for SAA, illus-
trating the potential of including either or both of these
APPs in an improved diagnostic test for sheep scab
where knowledge of current disease status is important.
For example, in the case of the Sheep Scab (Scotland)
Order 2010, where confirmation of successful treatment
is required before movement restrictions are lifted from
the affected farm. The legislation allows lifting of move-
ment restrictions to occur 16 days following successful
treatment, when it is still difficult to assess by clinical
examination. However, if Hp and /or SAA were used as
BMs of current disease status, they would have returned
to baseline levels before 16 days indicating successful
treatment, as shown in Figure 5a and 5b.
SAA was a more accurate discriminatory indicator of
current disease status in the PIT study than Hp, due to
the higher sensitivity and specificity obtained for the
optimised cut-off values which were estimated using the
data from the primary infestation and post-treatment
element of the PIT trial.
At the cut-off levels established for SAA and Hp by
statistical analysis of the PIT experimental trial results, it
was evident that, during secondary experimental infest-
ation (i.e. re-infestation), mean Hp levels in the sera of
infested sheep were below the Hp cut-off point at all
time points. In addition, for SAA, mean sera levels were
above the cut-off point for 1 week only during this sec-
ondary infestation period. This may reflect the altered
immunological landscape during the pathogenesis of a
re-infestation, where lesion size and mite numbers are
reduced compared with primary lesions [5] and may rep-
resent a limitation for the use of BM assays although
field outbreak studies are now required to establish suit-
able cut-off values in practice.
When Hp and SAA levels were investigated during
other common diseases and conditions of sheep, they
were predominantly found to be at levels equivalent to
sheep scab negative values, remaining below 0.6 mg/mL
for Hp and 22 μg/mL for SAA. Importantly, as gastro-
intestinal nematodes (GIN) commonly affect sheep, Hp
and SAA levels were not elevated during the GIN ex-
perimental infections tested here. Although Hp was
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elevated in lice infestation in this analysis, it is evident
from the standard errors in these results that there was
large between animal variation and therefore these re-
corded measurements may be due to other underlying
conditions. Analysis of additional sera samples from
sheep infected with these diseases would therefore be
required to confirm serum levels of Hp and SAA dur-
ing these infections. In addition, as the BM assays react
to other inflammatory conditions, they should be used
in conjunction with the specific antibody assay which
has been developed for sheep scab diagnosis and has
been shown not to cross-react with other common
sheep diseases and conditions, including biting lice
[12]. Compared to Hp and SAA levels, the measure-
ment of Pso o 2-specific IgG provided earlier, specific,
diagnosis of P. ovis infestation as shown in Table 3,
where the majority of animals showed an elevated
antigen-specific IgG response to Pso o 2 in the primary
infestation by week 2 post-infestation. This was a simi-
lar response to that previously reported using this
assay [12]. While this assay therefore provides rapid,
sensitive and specific diagnosis of P. ovis infestation,
antibody persistence (Figure 5c and [13]) prevents ac-
curate diagnosis of current disease status e.g. after
treatment or on disease resolution. When the decreases in
Hp and SAA levels post-treatment were compared to
those of the Pso o 2 specific IgG levels, it was evident that
Hp and SAA gave a rapid indication of current disease sta-
tus post-treatment, whereas high Pso o 2-specific IgG
levels were still measurable 20 weeks post-treatment. The
differences in half life also illustrated the differing re-
sponses to treatment i.e. 56 days for the Pso o 2-specific
IgG response, compared to 2.3 days for Hp and 0.84 days
for SAA. However, as serum Hp and SAA levels increase
in many inflammatory diseases in ruminants [16] these
APPs could not be used in isolation for the diagnosis of
sheep scab. The relative merits of the tests measuring the
Pso o 2-specific IgG response and APP levels indicate that
a combined diagnostic test incorporating both elements
would result in a highly specific test which would indicate
both pathogen specific early infestation (Pso o 2-specific
IgG levels) and current disease status after treatment
(SAA and/or Hp levels). This would provide the sheep in-
dustry with a powerful diagnostic tool for sheep scab con-
trol or eradication schemes.
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